Stan Bernard, MD

"Payers have evolved to become powerful global contenders with pharma for increasingly limited funding of drug budgets."

Creative non-pharmaceutical partnerships can offer innovators unique capabilities against the competition in a new era where challenges to market leadership are coming from every direction.

Game-changers can create competitive advantages for pharmaceutical companies and products.

Increasingly, pharma companies are expanding from brand vs. brand to battle at the franchise, portfolio, and corporate levels.

Launching a product? Your competition likely plans to interfere. Here's how to counter a counter-launch.

Every industry has a life cycle, and pharma's has just entered its competitive stage. Here's how to prepare.

To harness consumerization to improve the industry's image and enhance the value of its products, pharma leaders need to focus on the "Four Cs": commitment, choice, collaboration, and customization

Prevailing notions about PGx are often based on misconceptions. But in reality, the Technology plays a vital role in pharma's business today.

It's time for the big project. Top management in a leading pharma company wants executive A, a rising star in the marketing department, to evaluate a new technology's impact on the industry-and on his company. The technology has the potential to dramatically affect not only pharmaceutical discovery and development but also marketing and sales. But there are many factors to analyze, and no one in his company has the expertise to do it.